Specifically, there was no statistical difference between KRAS-knockdown cells re-expressing Flag-KRASC118S and KRAS-knockdown cells with regards to tumor growth or tumor weight at endpoint (Fig 1C–1E). Here, KRAS is linked to neoplasm.